ATPC Agape ATP Corp
Services-Health Services · Nasdaq · SEC CIK 1713210 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-47.0%
TTM net income YoY76.2%
TTM EPS YoY98.5%
Revenue 3-yr CAGR-18.0%
Net income 3-yr CAGR—
Margins
Gross margin52.1%
Operating margin-372.9%
Net margin-82.9%
FCF margin—
EBITDA margin-372.4%
Returns
ROE-2.9%
ROA-2.6%
ROIC (approx.)-10.4%
Asset turnover0.03x
Leverage & solvency
Liabilities / assets13.2%
Debt / equity0.00x
Current ratio7.59x
Interest coverage—
Cash quality & payout
Operating cash flow / net income1.05x
Accruals ratio0.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.52M | $1.32M | $1.43M | $1.86M | $1.02M |
| Cost of revenue | $685,992 | $563,599 | $494,516 | $666,042 | $297,333 |
| Gross profit | $838,270 | $759,148 | $936,572 | $1.19M | $719,629 |
| SG&A expense | $3.78M | $3.13M | $2.37M | $1.96M | $1.75M |
| Operating income | -$3.26M | -$2.57M | -$2.15M | -$1.53M | -$1.86M |
| Pretax income | -$2.31M | -$2.48M | -$2.11M | -$1.67M | -$2.39M |
| Income tax | $2,285 | $4,934 | $3,575 | -$4,055 | $137,067 |
| Net income | -$2.28M | -$2.47M | -$2.10M | -$1.69M | -$2.52M |
| EBITDA | -$3.24M | -$2.52M | -$2.08M | -$1.46M | -$1.78M |
| EPS (basic) | -2.85 | -31.74 | -0.55 | -0.02 | -0.01 |
| EPS (diluted) | -2.85 | -31.74 | -0.55 | -0.02 | -0.01 |
| Weighted avg. shares (diluted) | 801,081 | 77,839 | 3.79M | 87.82M | 376.22M |
| Banking | |||||
| Deposits | $89,651 | $2.03M | $4.82M | $1.43M | $554,864 |
| Balance sheet | |||||
| Cash & equivalents | $89,651 | $1.99M | $4.83M | $1.44M | $2.60M |
| Receivables | $4,023 | $53,651 | $55,458 | $2,826 | — |
| Inventory | $26,148 | $46,347 | $47,907 | $46,277 | $375,535 |
| Current assets | $24.29M | $2.78M | $5.19M | $2.03M | $3.91M |
| PP&E, net | $5,140 | $31,463 | $77,858 | $142,149 | $215,799 |
| Intangibles | $1 | $13,082 | $17,458 | $24,044 | $3,660 |
| Total assets | $24.59M | $3.24M | $5.74M | $2.79M | $4.72M |
| Current liabilities | $2.05M | $1.12M | $1.07M | $1.23M | $1.31M |
| Total liabilities | $2.17M | $1.31M | $1.36M | $1.23M | $1.41M |
| Shareholders' equity | $22.46M | $1.93M | $4.37M | $1.54M | $3.31M |
| Shares outstanding | 1.00M | 79,781 | 3.86M | 75.45M | 290.46M |
| Cash flow statement | |||||
| Operating cash flow | -$2.41M | -$2.73M | -$2.00M | -$811,683 | -$845,842 |
| Capital expenditure | — | — | — | — | $3,959 |
| Free cash flow | — | — | — | — | -$849,801 |
| Investing cash flow | -$23.00M | -$50,050 | -$17,251 | -$32,119 | -$3,959 |
| Financing cash flow | $23.50M | -$11,856 | $5.40M | -$234,466 | -$19,061 |
| Depreciation & amortization | $20,189 | $52,570 | $70,337 | $71,754 | $75,797 |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.